Discover the key limitations of Randomized Controlled Trials (RCTs), including inefficiency in detecting rare outcomes, limited generalizability, high costs, and more. Learn why RCTs may not always be the ideal research design.
Table of Contents
Question
Select limitations of Randomized Controlled Trials
A. Inefficiency of detection of rare or delayed outcomes
B. Shorter-duration follow-up than observational studies
C. Limited external validity and generalizability
D. Higher cost than observational studies
E. Ability to evaluate causal relationships
Answer
A. Inefficiency of detection of rare or delayed outcomes
B. Shorter-duration follow-up than observational studies
C. Limited external validity and generalizability
D. Higher cost than observational studies
Explanation
Randomized Controlled Trials (RCTs) are considered the “gold standard” for evaluating causal relationships in clinical research. However, they come with significant limitations that can affect their applicability and efficiency in real-world settings. Below is a detailed explanation of the correct answer to your question.
Inefficiency in Detecting Rare or Delayed Outcomes (Option A)
RCTs are not well-suited for studying rare events or outcomes that take a long time to manifest. This is because they often require large sample sizes and extended follow-up periods to detect such effects, which may not be feasible due to logistical and financial constraints.
Shorter Follow-Up Duration Compared to Observational Studies (Option B)
Many RCTs have relatively short durations, typically ranging from 3 to 5 years. This limited timeframe may fail to capture long-term effects or “legacy effects” of an intervention, unlike observational studies that can span decades.
Limited External Validity and Generalizability (Option C)
The controlled environment of RCTs often does not reflect real-world conditions. The study population may be unrepresentative due to strict inclusion/exclusion criteria, making it difficult to generalize findings to broader patient populations or different healthcare settings.
Higher Cost Than Observational Studies (Option D)
Conducting an RCT is expensive due to the need for rigorous protocols, large sample sizes, and extensive monitoring. This makes them less cost-effective compared to observational studies like cohort or case-control designs.
Why Option E Is Incorrect
While RCTs are excellent for establishing causal relationships due to their randomization process, this is not a limitation but rather a strength of the study design. Therefore, it does not belong in the list of limitations.
Understanding these limitations is crucial for selecting the appropriate research design based on the research question and context.
Data Science with Real World Data in Pharma certification exam assessment practice question and answer (Q&A) dump including multiple choice questions (MCQ) and objective type questions, with detail explanation and reference available free, helpful to pass the Data Science with Real World Data in Pharma exam and earn Data Science with Real World Data in Pharma certification.